|
1
|
Liu J, Ren ZH, Qiang H, Wu J, Shen M,
Zhang L and Lyu J: Trends in the incidence of diabetes mellitus:
Results from the global burden of disease study 2017 and
implications for diabetes mellitus prevention. BMC Public Health.
20(1415)2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Pop A, Clenciu D, Anghel M, Radu S, Socea
B, Mota E, Mota M and Panduru NM: RomDiane Study Group. Insulin
resistance is associated with all chronic complications in type 1
diabetes. J Diabetes. 8:220–228. 2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Fowler MJ: Microvascular and macrovascular
complications of diabetes. Clin Diabetes. 26:77–82. 2008.
|
|
4
|
Mohammedi K, Woodward M, Marre M,
Colagiuri S, Cooper M, Harrap S, Mancia G, Poulter N, Williams B,
Zoungas S and Chalmers J: Comparative effects of microvascular and
macrovascular disease on the risk of major outcomes in patients
with type 2 diabetes. Cardiovasc Diabetol. 16(95)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Chawla A, Chawla R and Jaggi S:
Microvasular and macrovascular complications in diabetes mellitus:
Distinct or continuum? Indian J Endocrinol Metab. 20:546–551.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mor P, Rathore AR, Sonagra V, Sharma N and
Sharma A: A study of serum copper, zinc and magnesium in type 2
diabetes mellitus with complications and without complications.
Biomed Pharmacol J. 13:1927–1930. 2020.
|
|
7
|
Hasanato RM: Trace elements in type 2
diabetes mellitus and their association with glycemic control. Afr
Health Sci. 20:287–293. 2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Salgueiro MJ, Krebs N, Zubillaga MB, Weill
R, Postaire E, Lysionek AE, Caro RA, De Paoli T, Hager A and Boccio
J: Zinc and diabetes mellitus: Is there a need of zinc
supplementation in diabetes mellitus patients? Biol Trace Elem Res.
81:215–228. 2001.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Luo YY, Zhao J, Han XY, Zhou XH, Wu J and
Ji LN: Relationship between serum zinc level and microvascular
complications in patients with type 2 diabetes. Chin Med J (Engl).
128:3276–3282. 2015.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Miao X, Sun W, Miao L, Fu Y, Wang Y, Su G
and Liu Q: Zinc and diabetic retinopathy. J Diabetes Res.
2013(425854)2013.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Tudosie MS, Miulescu RD, Negulescu V,
Ionica M, Stefan DS, Corlan G and Macovei R: Evaluation and
modeling of pharmacokinetics of copper ion during hemodialysis.
Farmacia. 61:53–65. 2013.
|
|
12
|
Lee SR: Critical role of zinc as either an
antioxidant or a prooxidant in cellular systems. Oxid Med Cell
Longev. 2018(9156285)2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Giacco F and Brownlee M: Oxidative stress
and diabetic complications. Circ Res. 107:1058–1070.
2010.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lee R, Wong TY and Sabanayagam C:
Epidemiology of diabetic retinopathy, diabetic macular edema and
related vision loss. Eye Vis (Lond). 2(17)2015.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Zugravu CA, Baciu A, Patrascu D, Tarcea M
and Pantea Stoian A: Depression and diabetes: Are there any
consequences on self-care? Eur J Public Health. 22(272)2012.
|
|
16
|
Stoian AP, Mitrofan G, Colceag F,
Suceveanu AI, Hainarosi R, Pituru S, Diaconu CC, Timofte D, Nitipir
C, Poiana C and Serafinceanu C: Oxidative stress in diabetes a
model of complex thinking applied in medicine. Rev Chim.
69:2515–2519. 2018.
|
|
17
|
Serban D, Papanas N, Dascalu AM, Stana D,
Nicolae VA, Vancea G, Badiu CD, Tanasescu D, Tudor C, Balasescu SA
and Pantea-Stoian A: diabetic retinopathy in patients with diabetic
foot ulcer: A systematic review. Int J Low Extrem Wounds.
20:98–103. 2021.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Cheung N, Mitchell P and Wong TY: Diabetic
retinopathy. Lancet. 376:124–136. 2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Ugarte M, Osborne NN, Brown LA and Bishop
PN: Iron, zinc, and copper in retinal physiology and disease. Surv
Ophthalmol. 58:585–609. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Kang JH, Pasquale LR, Willett WC, Rosner
BA, Egan KM, Faberowski N and Hankinson SE: Dietary fat consumption
and primary open-angle glaucoma. Am J Clin Nutr. 79:755–764.
2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Anetor JI, Senjobi A, Ajose OA and
Agbedana EO: Decreased serum magnesium and zinc levels: Atherogenic
implications in type-2 diabetes mellitus in Nigerians. Nutr Health.
16:291–300. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Kumar DA, Priya VS, Jaiprabhu J and
Ramalingam K: Serum copper and zinc levels significance in type 2
diabetic patients. J Med Sci Tech. 3:79–81. 2014.
|
|
23
|
Ugarte M and Osborne NN: Zinc in the
retina. Prog Neurobiol. 64:219–249. 2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Li Y, Andereggen L, Yuki K, Omura K, Yin
Y, Gilbert HY, Erdogan B, Asdourian MS, Shrock C, de Lima S, et al:
Mobile zinc increases rapidly in the retina after optic nerve
injury and regulates ganglion cell survival and optic nerve
regeneration. Proc Natl Acad Sci USA. 114:E209–E218.
2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Redenti S and Chappell RL: Müller cell
zinc transporter-3 labeling suggests a role in outer retina zinc
homeostasis. Mol Med. 13:376–379. 2007.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Morrison SA, Russell RM, Carney EA and
Oaks EV: Zinc deficiency: A cause of abnormal dark adaptation in
cirrhotics. Am J Clin Nutr. 31:276–281. 1978.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Brunk UT, Wihlmark U, Wrigstad A, Roberg K
and Nilsson SE: Accumulation of lipofuscin within retinal pigment
epithelial cells results in enhanced sensitivity to
photo-oxidation. Gerontology. 41 (Suppl 2):S201–S212.
1995.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Nita M and Grzybowski A: The role of the
reactive oxygen species and oxidative stress in the pathomechanism
of the age-related ocular diseases and other pathologies of the
anterior and posterior eye segments in adults. Oxid Med Cell
Longev. 2016(3164734)2016.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Yahya H, Yahya KM and Saqib A: Minerals
and type 2 diabetes mellitus-level of zinc, magnesium and chromium
in diabetic and non diabetic population. JUMDC. 2:34–38. 2011.
|
|
30
|
Praveena S, Pasula S and Sameera K: Trace
elements in diabetes mellitus. J Clin Diagn Res. 7:1863–1865.
2013.
|
|
31
|
Fung EB, Gildengorin G, Talwar S, Hagar L
and Lal A: Zinc status affects glucose homeostasis and insulin
secretion in patients with thalassemia. Nutrients. 7:4296–4307.
2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Ranasinghe P, Wathurapatha WS, Galappatthy
P, Katulanda P, Jayawardena R and Constantine GR: Zinc
supplementation in prediabetes: A randomized double-blind
placebo-controlled clinical trial. J Diabetes. 10:386–397.
2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Devi TR, Hijam D, Dubey A, Debnath S,
Oinam P, Devi NT and Singh W: Study of Serum Zinc and Copper levels
in Type 2 Diabetes Mellitus. Int J Contemp Med Res. 3:1036–1040.
2016.
|
|
34
|
Al-Maroof RA and Al-Sharbatti SS: Serum
zinc levels in diabetic patients and effect of zinc supplementation
on glycemic control of type 2 diabetics. Saudi Med J. 27:344–350.
2006.PubMed/NCBI
|
|
35
|
Walter RM Jr, Uriu-Hare JY, Olin KL, Oster
MH, Anawalt BD, Critchfield JW and Keen CL: Copper, zinc,
manganese, and magnesium status and complications of diabetes
mellitus. Diabetes Care. 14:1050–1056. 1991.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Saharia GK and Goswami RK: Evaluation of
serum zinc status and glycated hemoglobin of type 2 diabetes
mellitus patients in a tertiary care hospital of assam. J Lab
Physicians. 5:30–33. 2013.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Anderson RA, Roussel AM, Zouari N, Mahjoub
S, Matheau JM and Kerkeni A: Potential antioxidant effects of zinc
and chromium supplementation in people with type 2 diabetes
mellitus. J Am Coll Nutr. 20:212–218. 2001.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Jansen J, Karges W and Rink L: Zinc and
diabetes-clinical links and molecular mechanisms. J Nutr Biochem.
20:399–417. 2009.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Brun JF, Fons C, Fussellier M, Bardet L
and Orsetti A: Urinary zinc and its relationships with
microalbuminuria in type I diabetics. Biol Trace Elem Res.
32:317–323. 1992.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Poudel RR, Bhusal Y, Tharu B and Kafle NK:
Role of zinc in insulin regulation and diabetes. J Soc Health
Diabetes. 5:83–87. 2017.
|
|
41
|
Tudosie MS, Truta E, Davitoiu AM,
Stanciulescu L, Jinescu G, Mitu AM, Forje M, Horhota L, Bojescu AA,
Mares AM and Ionica M: The impact of copper in children with
attention deficit hyperactivity disorder. Rev Chim. 68:279–283.
2017.
|
|
42
|
Naismith RT, Shepherd JB, Weihl CC, Tutlam
NT and Cross AH: Acute and bilateral blindness due to optic
neuropathy associated with copper deficiency. Arch Neurol.
66:1025–1027. 2019.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Jaiser SR and Winston GP: Copper
deficiency myelopathy. J Neurol. 257:869–881. 2010.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Shah AR and Tamhankar MA: Optic neuropathy
associated with copper deficiency after gastric bypass surgery.
Retin Cases Brief Rep. 8:73–76. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Klevay LM: Ocular lesions from copper
deficiency. Indian J Med Res. 146:430–431. 2017.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Gregg XT, Reddy V and Prchal JT: Copper
deficiency masquerading as myelodysplastic syndrome. Blood.
100:1493–1495. 2002.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Spinazzi M, De Lazzari F, Tavolato B,
Angelini C, Manara R and Armani M: Myelo-optico-neuropathy in
copper deficiency occurring after partial gastrectomy. Do small
bowel bacterial overgrowth syndrome and occult zinc ingestion tip
the balance? J Neurol. 254:1012–1017. 2007.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Rapoport Y and Lavin PJ: Nutritional optic
neuropathy caused by copper deficiency after bariatric surgery. J
Neuroophthalmol. 36:178–181. 2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Pineles SL, Wilson CA, Balcer LJ, Slater R
and Galetta SL: Combined optic neuropathy and myelopathy secondary
to copper deficiency. Surv Ophthalmol. 55:386–392. 2010.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Dake Y and Amemiya T: Electron microscopic
study of the optic nerve in copper deficient rats. Exp Eye Res.
52:277–281. 1991.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Civelek S, Gelişgen R, Andican G, Seven A,
Küçük SH, Ozdoğan M and Burçak G: Advanced glycation end products
and antioxidant status in nondiabetic and streptozotocin induced
diabetic rats: Effects of copper treatment. Biometals. 23:43–49.
2010.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Balsano C, Porcu C and Sideri S: Is copper
a new target to counteract the progression of chronic diseases?
Metallomics. 10:1712–1722. 2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Aigner E, Weiss G and Datz C:
Dysregulation of iron and copper homeostasis in nonalcoholic fatty
liver. World J Hepatol. 7:177–188. 2015.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Lowe J, Taveira-da-Silva R and
Hilário-Souza E: Dissecting copper homeostasis in diabetes
mellitus. IUBMB Life. 69:255–262. 2017.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Arciello M, Longo A, Viscomi C, Capo C,
Angeloni A, Rossi L and Balsano C: Core domain mutant Y220C of p53
protein has a key role in copper homeostasis in case of free fatty
acids overload. Biometals. 28:1017–1029. 2015.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Jung UJ and Choi MS: Obesity and its
metabolic complications: The role of adipokines and the
relationship between obesity, inflammation, insulin resistance,
dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci.
15:6184–6223. 2011.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Zhang S, Liu H, Amarsingh GV, Cheung CC,
Hogl S, Narayanan U, Zhang L, McHarg S, Xu J, Gong D, et al:
Diabetic cardiomyopathy is associated with defective myocellular
copper regulation and both defects are rectified by divalent copper
chelation. Cardiovasc Diabetol. 13(100)2014.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Stättermayer AF, Traussnigg S, Aigner E,
Kienbacher C, Huber-Schönauer U, Steindl-Munda P, Stadlmayr A, Wrba
F, Trauner M, Datz C and Ferenci P: Low hepatic copper content and
PNPLA3 polymorphism in non-alcoholic fatty liver disease in
patients without metabolic syndrome. J Trace Elem Med Biol.
39:100–107. 2017.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Peng KY, Watt MJ, Rensen S, Greve JW,
Huynh K, Jayawardana KS, Meikle PJ and Meex RC: Mitochondrial
dysfunction-related lipid changes occur in nonalcoholic fatty liver
disease progression. J Lipid Res. 59:1977–1986. 2018.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Hilário-Souza E, Cuillel M, Mintz E,
Charbonnier P, Vieyra A, Cassio D and Lowe J: Modulation of hepatic
copper-ATPase activity by insulin and glucagon involves protein
kinase A (PKA) signaling pathway. Biochim Biophys Acta.
1862:2086–2097. 2016.PubMed/NCBI View Article : Google Scholar
|
|
61
|
Di-Silvestro RA: Zinc in relation to
diabetes and oxidative disease. J Nutr. 130 (Suppl 5):1509S–1511S.
2000.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Zarga AH, Shah NA, Masoodi SR, Laway BA,
Dar FA, Khan AR, Sofi FA and Wani AI: Copper, zinc, and magnesium
levels in non-insulin dependent diabetes mellitus. Postgrad Med J.
74:665–668. 1998.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Eaton JW and Qian M: Interactions of
copper with glycated proteins: Possible involvement in the etiology
of diabetic neuropathy. Mol Cell Biochem. 234-235:135–142.
2002.PubMed/NCBI
|
|
64
|
Argirova MD and Ortwerth BJ: Activation of
protein-bound copper ions during early glycation: Study on two
proteins. Arch Biochem Biophys. 420:176–184. 2003.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Cruz KJ, de Oliveira AR and Marreiro Ddo
N: Antioxidant role of zinc in diabetes mellitus. World J Diabetes.
6:333–337. 2015.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Ganiger A, Swamy MK, Shankar Prasad DS,
Mannangi NB and Gundalli S: Study of serum copper and zinc in
diabetic retinopathy and its correlation with glycemic status. Int
J Clin Biochem Res. 3:76–81. 2016.
|
|
67
|
Rodríguez-Menéndez S, García M, Fernández
B, Álvarez L, Fernández-Vega-Cueto A, Coca-Prados M, Pereiro R and
González-Iglesias H: The zinc-metallothionein redox system reduces
oxidative stress in retinal pigment epithelial cells. Nutrients.
10(1874)2018.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Farooq DM, Alamri AF, Alwhahabi BK,
Metwally AM and Kareem KA: The status of zinc in type 2 diabetic
patients and its association with glycemic control. J Family
Community Med. 27:29–36. 2020.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Osredkar J and Sustar N: Copper and zinc,
biological role and significance of copper/zinc imbalance. J Clinic
Toxicol. S3:001–018. 2011.
|
|
70
|
Rostamkhani H, Mellati AA, Tabaei BS,
Alavi M and Mousavi SN: Association of serum zinc and vitamin A
levels with severity of retinopathy in type 2 diabetic patients: A
cross-sectional study. Biol Trace Elem Res. 192:123–128.
2019.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Pantea Stoian A, Pricop-Jeckstadt M, Pana
A, Ileanu BV, Schitea R, Geanta M, Catrinoiu D, Suceveanu AI,
Serafinceanu C, Pituru S, et al: Death by SARS-CoV 2: A Romanian
COVID-19 multi-centre comorbidity study. Sci Rep.
10(21613)2020.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Hui Y, Li Y, Tong X, Wang Z, Mao X, Huang
L and Zhang D: The risk factors for mortality of diabetic patients
with severe COVID-19: A retrospective study of 167 severe COVID-19
cases in Wuhan. PLoS One. 15(e0243602)2020.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Stoian AP, Papanas N, Prazny M, Rizvi AA
and Rizzo M: Incretin-based therapies role in COVID-19 era:
Evolving insights. J Cardiovasc Pharmacol Ther. 25:494–496.
2020.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Dennis JM, Mateen BA, Sonabend R, Thomas
NJ, Patel KA, Hattersley AT, Denaxas S, McGovern AP and Vollmer SJ:
Type 2 diabetes and COVID-19-related mortality in the critical care
setting: A national cohort study in england, march-july 2020.
Diabetes Care. 44:50–57. 2021.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Roussel AM, Kerkeni A, Zouari N, Mahjoub
S, Matheau JM and Anderson RA: Antioxidant effects of zinc
supplementation in Tunisians with type 2 diabetes mellitus. J Am
Coll Nutr. 22:316–321. 2003.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Mousavi SN, Faghihi A, Motaghinejad M,
Shiasi M, Imanparast F, Amiri HL and Shidfar F: Zinc and selenium
co-supplementation reduces some lipid peroxidation and angiogenesis
markers in a rat model of NAFLD-fed high fat diet. Biol Trace Elem
Res. 181:288–295. 2018.PubMed/NCBI View Article : Google Scholar
|
|
77
|
Naghizadeh S, Kheirouri S, Ojaghi H and
Jafari Kaffash A: Zinc supplementation attenuate diabetic indices
in patients with diabetic retinopathy. Progr Nutr. 20 (Suppl
2):S263–S269. 2018.
|
|
78
|
Senapati A, Slavin BM and Thompson RP:
Zinc depletion and complications of surgery. Clin Nutr. 9:341–346.
1990.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Adjepong D, Jahangir S and Malik B: The
effect of zinc on post-neurosurgical wound healing: A review.
Cureus. 12(e6770)2020.PubMed/NCBI View Article : Google Scholar
|
|
80
|
Duncan A, Yacoubian C, Watson N and
Morrison I: The risk of copper deficiency in patients prescribed
zinc supplements. J Clin Pathol. 68:723–725. 2015.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Cooper GJ: Selective divalent copper
chelation for the treatment of diabetes mellitus. Curr Med Chem.
19:2828–2860. 2012.PubMed/NCBI View Article : Google Scholar
|
